Inogen (INGN) Free Cash Flow (2013 - 2026)
Inogen (INGN) reported Free Cash Flow of -$6.9 million for Q1 2026, up 59.64% year-over-year from -$4.3 million in Q1 2025, and down 475.54% quarter-over-quarter from -$1.2 million in Q4 2025.
Inogen (INGN) Free Cash Flow (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Free Cash Flow data on file, last reported at -$6.9 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$6.9 million, up 59.64% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.4 million (up 83.02% YoY), and the FY2025 annual result was -$11.6 million, down 555.17% from the prior year.
- Free Cash Flow fell to -$6.9 million in Q1 2026 per INGN's latest filing, from -$1.2 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $7.8 million in Q2 2024 and troughed at -$18.5 million in Q4 2022.
- A 5-year average of -$3.5 million and a median of -$1.5 million in 2023 frame the typical range for Free Cash Flow.
- On a YoY basis, Free Cash Flow climbed as much as 566.6% in 2024 and fell as far as 1438.14% in 2024.
- A 5-year view of Free Cash Flow shows it stood at -$18.5 million in 2022, then soared by 102.55% to $472000.0 in 2023, then plunged by 1438.14% to -$6.3 million in 2024, then surged by 81.03% to -$1.2 million in 2025, then tumbled by 475.54% to -$6.9 million in 2026.
- Business Quant data shows INGN's Free Cash Flow at -$6.9 million in Q1 2026, -$1.2 million in Q4 2025, and $3.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 245.20 Mn |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn | -6.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.90 Mn |
| Mar 31, 2026 | -6.90 Mn |
| Dec 31, 2025 | -1.20 Mn |
| Dec 31, 2025 | -1.20 Mn |
| Sep 30, 2025 | 2.99 Mn |
| Sep 30, 2025 | 2.99 Mn |
| Jun 30, 2025 | 3.67 Mn |
| Jun 30, 2025 | 3.67 Mn |
| Mar 31, 2025 | -17.08 Mn |
| Mar 31, 2025 | -17.08 Mn |
| Dec 31, 2024 | -6.32 Mn |
| Dec 31, 2024 | -6.32 Mn |
| Sep 30, 2024 | 7.11 Mn |
| Sep 30, 2024 | 7.11 Mn |
| Jun 30, 2024 | 7.82 Mn |
| Jun 30, 2024 | 7.82 Mn |
| Mar 31, 2024 | -6.06 Mn |
| Mar 31, 2024 | -6.06 Mn |
| Dec 31, 2023 | 472,000.00 |
| Dec 31, 2023 | 472,000.00 |